Skip to content

Proudly supported by

Speakers

Greg Evans

Program Director at the National Cancer Institute

Lindsay Pino

CTO & Cofounder at Talus Bio

Trevor Levin

Founder & CEO at Convergent Genomics

Emmanuel Akporiaye

Founder and CEO at Veana Therapeutics Inc

Ivan Liachko

Founder & CEO at Phase Genomics

Molika Ashford

Editor at GenomeWeb

Hosted by

Phase Genomics

Phase Genomics applies Hi-C and other proximity ligation methods to enable metagenomic, viral, and AMR discovery, chromosome-scale genome assembly, as well as analysis of structural variation and genome architecture. We offer a comprehensive portfolio of laboratory and computational services and products. These include proximity ligation (Hi-C) kits for plants, animals, microbes, and human samples, as well as industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company's mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.

Share on